About PT141

PT141 (Bremelanotide) works through the melanocortin system — specifically targeting MC3R and MC4R receptors in the brain — rather than acting on the vascular system. This central mechanism makes it distinct from other compounds and has been researched for sexual health and desire in both men and women. Key Research Highlights: • Acts centrally via melanocortin receptors (MC3R and MC4R) in the hypothalamus • Researched for sexual desire, arousal, and dysfunction in both men and women • Non-vascular mechanism of action — does not directly affect blood pressure pathways • Studied for hypoactive sexual desire disorder (HSDD) • Effects may be relevant across a broad age range

Product Information